Clay Siegall manages Seattle Genetics as the CEO, and he is a researcher who deal in cancer drugs. He has built many different drugs that are perfect for the marketplace, and he is gaining the trust of doctors who are seeing results in their patients. This article explains how Seattle Genetics offers better cancer drugs for the market, and there is a look at how Clay Siegall has made the company better.
#1: What Cancer Drugs Does The Company Work On?
Seattle Genetics has produced two different cancer drugs using antibody research that was started by Clay. He was one of the first to use such a technique, and he wants to ensure patients have a higher rate of success with the drugs. He is thinking of creating up to a dozen drugs, and they are all based on the research that he began.
#2: He Funds The Company Well
Clay has done quite a lot of work funding the company, and he has secured quite a high stock value in addition to funding that reaches the company every year. He is helping the company raise funds for new research projects, and he has the company selling nearly $100 million in drugs a year.
#3: Partnerships In The Industry
The industry partnerships at Seattle Genetics are quite strong, and they involve research and distribution that is completed through the Seattle Genetics lab. The company is open to every other firm that needs research assistance, and they have a large staff that reaches out to other firms every day to share their results. They wish to improve results for all patients, and they do so with help from the Seattle Genetics team. More drugs are produced to help people, and they are made to ensure there is a cure for those who are struggling with cancer.
The medications produced by Clay Siegall are created using science he researched himself. He now manages the company as CEO, and he ensures there is a way to reach more people with each medication. Seattle Genetics is offering a better cancer treatment for every doctor who orders.